TA
MRSN

Teachers Advisors’s Mersana Therapeutics MRSN Stock Holding History

Teachers Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$107K Hold
811
– – ﹤0.01% 2925
2018
Q4 		$83K Buy
811
+102
+14% +$16.1K ﹤0.01% 2966
2018
Q3 		$177K Hold
709
– – ﹤0.01% 2959
2018
Q2 		$317K Buy
709
+169
+31% +$74.2K ﹤0.01% 2852
2018
Q1 		$213K Buy
540
+305
+130% +$120K ﹤0.01% 2868
2017
Q4 		$96K Hold
235
– – ﹤0.01% 3005
2017
Q3 		$101K Buy
+235
New +$92.6K ﹤0.01% 3032

Other funds holding MRSN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Teachers Advisors's MRSN Position: Q1 2019 in Review

Teachers Advisors held its Mersana Therapeutics (MRSN) position steady in Q1 2019 at 811 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2925.

Teachers Advisors first reported a position in MRSN in Q3 2017 and has held it in 7 quarters since. The position peaked at $317K in Q2 2018. 65 funds tracked by Wall St. Rank hold MRSN as of Q1 2019.

  • Teachers Advisors held 811 shares of Mersana Therapeutics worth $107K as of Q1 2019.
  • Teachers Advisors left its Mersana Therapeutics share count unchanged in Q1 2019.
  • Mersana Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2925 holding.
  • Teachers Advisors first reported a position in Mersana Therapeutics in Q3 2017 and has held it in 7 quarters since.
  • Teachers Advisors's Mersana Therapeutics position peaked at $317K in Q2 2018.
  • 65 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.